Secretory Phospholipase A2 is an enzyme that hydrolyses the sn-2 ester bond of phospholipids, generating non-esterified free fatty acids and lysophospholipids (1‑3). PLA2G2A is a calcium-dependent phospholipase expressed in many cell types participating in inflammation-associated cellular responses, including platelets, neutrophils, and mast cells. It may function as an enzymatic component of the host defense mechanism. For example, human tears contain a high concentration of PLA2G2A, a principal bactericidal factor against Gram-positive bacteria in this fluid. It may play a role in cell proliferation through binding a receptor on the cell membrane. PLA2G2A has been shown to have pro-atherogenic properties both in the circulation and within the arterial wall (4). It is an acute phase protein expressed in response to a variety of pro-inflammatory cytokines. Circulating levels of sPLA2G2A are higher in coronary artery disease (CAD) patients and are associated with increased risk of future CAD (5).
Recombinant Mouse PLA2G2A Protein, CF
R&D Systems | Catalog # 4925-PL
Loading...
Key Product Details
- R&D Systems Sf 21 (baculovirus)-derived Recombinant Mouse PLA2G2A Protein (4925-PL)
- Quality control testing to verify active proteins with lot specific assays by in-house scientists
- All R&D Systems proteins are covered with a 100% guarantee
Source
Sf 21 (baculovirus)
Accession Number
Applications
Enzyme Activity
Loading...
Product Specifications
Source
Spodoptera frugiperda, Sf 21 (baculovirus)-derived mouse PLA2G2A protein
Asn22-Cys146, with a C-terminal 10-His tag
Asn22-Cys146, with a C-terminal 10-His tag
Purity
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Endotoxin Level
<1.0 EU per 1 μg of the protein by the LAL method.
N-terminal Sequence Analysis
Asn22
Predicted Molecular Mass
15 kDa
SDS-PAGE
17 kDa, reducing conditions
Activity
Measured by its ability to hydrolyze 1-Hexadecanoyl-2-(1-pyrene-decanoyl)-sn-glycero-3-phosphocholine.
The specific activity is >50 pmol/min/µg, as measured under the described conditions.
The specific activity is >50 pmol/min/µg, as measured under the described conditions.
Formulation, Preparation, and Storage
4925-PL
| Formulation | Supplied as a 0.2 μm filtered solution in Sodium Acetate and NaCl. |
| Shipping | The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: PLA2G2A
References
- Webb, N. R. (2005) Cur. Opin. Lipid. 16:341.
- Triggiani, M. et al. (2005) J. Allergy Clin. Immunol. 116:1000.
- Murakami, M. and Kudo, I. (2004) Biol. Pharm. Bull. 27:1158.
- de Beer, F. C. and Webb, N. R. (2006) Arterioscler. Thromb. Vasc. Biol. 26:1421.
- Wootton, P. T. E. et al. (2006) Human Mol. Genet. 15:355.
Long Name
Phospholipase A2 Group IIA
Alternate Names
Mom1, PLA2B, PLA2L, RASF-A
Gene Symbol
PLA2G2A
UniProt
Additional PLA2G2A Products
Product Documents for Recombinant Mouse PLA2G2A Protein, CF
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Note: Certificate of Analysis not available for kit components.
Product Specific Notices for Recombinant Mouse PLA2G2A Protein, CF
For research use only
Related Research Areas
Customer Reviews for Recombinant Mouse PLA2G2A Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Mouse PLA2G2A Protein, CF and earn rewards!
Have you used Recombinant Mouse PLA2G2A Protein, CF?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
Protocols
View specific protocols for Recombinant Mouse PLA2G2A Protein, CF (4925-PL):
Materials
- Assay Buffer: 50 mM Tris, 500 mM NaCl, 1 mg/mL BSA, pH 8.5.
- Substrate Buffer: 50 mM Tris, 500 mM NaCl, 20 mM CaCl2, 1 mg/mL BSA, pH 8.5.
- Recombinant Mouse Phospholipase A2 Group IIA/PLA2G2A (rmPLA2G2A) (Catalog # 4925-PL)
- Substrate: 1-hexadecanoyl-2-(1-pyrene-decanoyl)-sn-glycero-3-phosphocholine (Invitrogen, Catalog # H361), Dilute to 2 mM in DMSO, then dilute to a final stock concentration of 400 µM in ethanol
- F16 Black Maxisorp Plate (Nunc, Catalog # 475515)
- Fluorescent Plate Reader (Model: SpectraMax Gemini EM by Molecular Devices) or equivalent
- Thaw Substrate at 37 °C for five minutes. Mix well.
- Dilute rmPLA2G2A to 2 ng/µL in Assay Buffer.
- Dilute substrate PGPC to 20 µM in Substrate Buffer.
- Load in plate 50 µL of 2 ng/µL rmPLA2G2A, and start the reaction by adding 50 µL of 20 µM Substrate to each well. Include a Substrate Blank containing 50 µL Assay Buffer and 50 µL Substrate.
- Read at excitation and emission wavelengths of 345 nm and 395 nm (top read), respectively, in kinetic mode for 5 minutes.
- Calculate specific activity:
|
Specific Activity (pmol/min/µg) = |
Adjusted Vmax* (RFU/min) x Conversion Factor** (pmol/RFU) |
| amount of enzyme (µg) |
*Adjusted for Substrate Blank
**Derived using calibration standard 1-pyrenedecanoic acid (Invitrogen, Catalog # P31).
- rmPLA2G2A: 0.1 µg
- Substrate: 10 µM